TY - JOUR
T1 - A simple, efficient and economical method for isolating and culturing human umbilical cord blood‑derived mesenchymal stromal cells
AU - Zhang, Junhe
AU - Zhao, Junli
AU - Mao, Qinwen
AU - Xia, Haibin
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Mesenchymal stromal cells (MSCs) hold broad therapeutic potential in various diseases, however, it is difficult to produce sufficient numbers of MSCs for clinical application, therefore, improved culture systems are required. The present study aimed to develop a novel method for isolating and culturing human umbilical cord blood‑derived mesenchymal stromal cells (hUCB‑MSCs). A sequential culture method was developed that uses two types of culture media to optimize the isolation and culture of hUCB‑MSCs. First, DMEM supplemented with mesenchymal stem cell growth supplement was used to improve the colony formation and primary culture success rates of hUCB‑MSCs. Then, after removing the heterogeneous cell population, ordinary DMEM was used from the fourth passage. This method obtained hUCB‑MSCs with high culture efficiency and at a greatly reduced cost. The optimal culture conditions were determined and the hUCB‑MSCs were phenotypically characterized after passaging. Taken together, this simple, efficient and economical method can produce a large number of high‑quality hUCB‑MSCs in <1 month, therefore facilitating the future clinical applications of hUCB‑MSCs.
AB - Mesenchymal stromal cells (MSCs) hold broad therapeutic potential in various diseases, however, it is difficult to produce sufficient numbers of MSCs for clinical application, therefore, improved culture systems are required. The present study aimed to develop a novel method for isolating and culturing human umbilical cord blood‑derived mesenchymal stromal cells (hUCB‑MSCs). A sequential culture method was developed that uses two types of culture media to optimize the isolation and culture of hUCB‑MSCs. First, DMEM supplemented with mesenchymal stem cell growth supplement was used to improve the colony formation and primary culture success rates of hUCB‑MSCs. Then, after removing the heterogeneous cell population, ordinary DMEM was used from the fourth passage. This method obtained hUCB‑MSCs with high culture efficiency and at a greatly reduced cost. The optimal culture conditions were determined and the hUCB‑MSCs were phenotypically characterized after passaging. Taken together, this simple, efficient and economical method can produce a large number of high‑quality hUCB‑MSCs in <1 month, therefore facilitating the future clinical applications of hUCB‑MSCs.
UR - http://www.scopus.com/inward/record.url?scp=85074621293&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074621293&partnerID=8YFLogxK
U2 - 10.3892/mmr.2019.10767
DO - 10.3892/mmr.2019.10767
M3 - Article
C2 - 31661118
AN - SCOPUS:85074621293
SN - 1791-2997
VL - 20
SP - 5257
EP - 5264
JO - Molecular Medicine Reports
JF - Molecular Medicine Reports
IS - 6
ER -